14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NBIX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Neurocrine Biosciences
(Updated on Jun 14, 2024)

Sell candidate since Jun 12, 2024 Gain 0.62% PDF

The Neurocrine Biosciences stock price fell by -0.594% on the last day (Friday, 14th Jun 2024) from $136.26 to $135.45. During the last trading day the stock fluctuated 1.42% from a day low at $134.14 to a day high of $136.05. The price has been going up and down for this period, and there has been a 0.03% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -134 thousand shares and in total, 400 thousand shares were bought and sold for approximately $54.14 million.

The stock is moving within a horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Neurocrine Biosciences stock with a 90% probability to be traded between $127.38 and $139.30 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NBIX Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, June 06, 2024, and so far it has risen 1.79%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Neurocrine Biosciences stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $138.15. On a fall, the stock will find some support from the short-term average at $134.60. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Neurocrine Biosciences stock

Neurocrine Biosciences finds support from accumulated volume at $135.41 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $1.91 (1.42%) between high and low. For the last week, the stock has had daily average volatility of 2.19%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NBIX) For The Upcoming Trading Day Of Monday 17th

For the upcoming trading day on Monday, 17th we expect Neurocrine Biosciences to open at $135.21, and during the day (based on 14 day Average True Range), to move between $131.55 and $139.35, which gives a possible trading interval of +/-$3.90 (+/-2.88%) up or down from last closing price. If Neurocrine Biosciences takes out the full calculated possible swing range there will be an estimated 5.76% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $135.41 (0.03%) than the resistance at $140.09 (3.43%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Neurocrine Biosciences stock A Buy?

Neurocrine Biosciences holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.608 Sell Candidate Unchanged

Predicted Opening Price for Neurocrine Biosciences of Monday, June 17, 2024

Fair opening price June 17, 2024 Current price
$135.21 ( 0.175%) $135.45

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NBIX

Fibonacci Support & Resistance Levels

Level Price
R3 137.12 1.24%
R2 136.39 0.697%
R1 135.94 0.364%
Price 135.45
S1 134.48 -0.713%
S2 134.03 -1.05%
S3 133.30 -1.58%

Accumulated Volume Support & Resistance Levels

Level Price
R3 143.74 6.12%
R2 143.03 5.60%
R1 140.09 3.43%
Price 135.45
S1 135.41 -0.0295%
S2 134.62 -0.613%
S3 133.48 -1.45%

FAQ

What is the symbol for Neurocrine Biosciences Stock and on which exchange is it traded?
The symbol for Neurocrine Biosciences is NBIX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Neurocrine Biosciences Stock?
Neurocrine Biosciences holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Neurocrine Biosciences Stock?
Neurocrine Biosciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Neurocrine Biosciences Stock.

What's the current price of Neurocrine Biosciences Stock?
As of the end of day on the Jun 14, 2024, the price of an Neurocrine Biosciences (NBIX) share was $135.45.

What is the 52-week high and low for Neurocrine Biosciences Stock?
The 52-week high for Neurocrine Biosciences Stock is $148.37 and the 52-week low is $93.29.

What is the market capitalization of Neurocrine Biosciences Stock?
As of the Jun 14, 2024, the market capitalization of Neurocrine Biosciences is 13.631B.

When is the next earnings date for Neurocrine Biosciences?
The upcoming earnings date for Neurocrine Biosciences is Aug 06, 2024.
Click to get the best stock tips daily for free!

About Neurocrine Biosciences

Neurocrine Biosciences Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products include ON... NBIX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT